Nephros
NEPH
18 hedge funds and large institutions have $3.95M invested in Nephros in 2022 Q3 according to their latest regulatory filings, with 3 funds opening new positions, 7 increasing their positions, 2 reducing their positions, and 2 closing their positions.
250% more repeat investments, than reductions
Existing positions increased: 7 | Existing positions reduced: 2
50% more first-time investments, than exits
New positions opened: 3 | Existing positions closed: 2
6% more funds holding
Funds holding: 17 → 18 (+1)
0.5% more ownership
Funds ownership: 41.55% → 42.05% (+0.5%)
98% less capital invested
Capital invested by funds: $176M → $3.95M (-$172M)
100% less funds holding in top 10
Funds holding in top 10: 1 → 0 (-1)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Vanguard Group
Malvern,
Pennsylvania
|
+$35.5K |
| 2 |
Renaissance Technologies
New York
|
+$31.5K |
| 3 |
VF
Virtu Financial
New York
|
+$24.2K |
| 4 |
EP
Elkhorn Partners
Omaha,
Nebraska
|
+$23.1K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$16K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
CPA
Cowen Prime Advisors
New York
|
-$65K |
| 2 |
BA
Bard Associates
Chicago,
Illinois
|
-$16.4K |
| 3 |
Morgan Stanley
New York
|
-$4.19K |
| 4 |
TCWM
Total Clarity Wealth Management
St. Charles,
Illinois
|
-$3K |
NEPH Hedge Fund Activity: Q3 2022 in Review
18 of the 5,829 institutional investors tracked by Wall St. Rank reported a position in Nephros (NEPH) for Q3 2022, worth a combined $3.95M — down 98% from $176M a quarter earlier.
Buyers outnumbered sellers: 3 funds opened new NEPH positions and 2 closed out — a net gain of 1 holder — while 7 added to existing stakes and 2 trimmed.
The largest buyer was Vanguard Group, adding an estimated $35.5K. The largest seller was Cowen Prime Advisors, exiting entirely with an estimated $65K sold.
- 18 institutional investors held Nephros (NEPH) as of Q3 2022, up from 17 in Q2 2022.
- Funds reported $3.95M of Nephros stock for Q3 2022, down 98% quarter-over-quarter.
- 3 funds opened new Nephros positions in Q3 2022 and 2 closed out, a net change of +1 holder.
- The largest Nephros buyer in Q3 2022 was Vanguard Group, an estimated $35.5K added.
- The largest Nephros seller in Q3 2022 was Cowen Prime Advisors, an estimated $65K sold.
Based on aggregated 13F filings for Q3 2022.